Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,824.66
(
0.62%
)
US TECH 100
24,378.40
(
0.56%
)
Dow Jones
48,185.80
(
0.58%
)
Brent Oil
94.38
(
-0.07%
)
Bitcoin
72,234.57
(
0.62%
)
News Focus
News Focus
Post# of 257375
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122860
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: biotech_researcher post# 156613

Thursday, 02/07/2013 3:57:53 PM

Thursday, February 07, 2013 3:57:53 PM

Post# of 257375

The only thing worse for the destruction of shareholder value in an established pharma other than Elan is what Phillip Frost did to Ivax Pharma many years ago.

Please clarify. Did you think IVAX sold out too cheaply to Teva?

I think he has resurfaced in some biotech recently.

You’re thinking of OPK.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today